News blog


  • BY: Andrew Hore |
  • POSTED: 22/01/2018 |

Neuroscience-focused digital data analysis technology developer IXICO is increasing its revenues and this is cutting the reported loss.

Four contracts worth a total of £3m have been won in recent months. These contracts cover wearable biosensor and Huntingdon’s disease.

In the year to September 2017, revenues were one-quarter higher at £4.1m and the loss fell from £2.9m to £1.9m. There was £2.4m in the bank at the end of the period. Research and development tax credits reduced the cash outflow but it was still £693,000 over the 12 months.

IXICO founder Derek Hill has left the board.

At 35.1p, the share price is near to a 12 month high. 

© 2019 Aim Micro. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

News Blog
All micro news

Oracle Power

Lignite coal mine and power plant developer Oracle Power has raised £500,000 at 0.425p a share. 

Continue reading... | 22/02/2019

LiDCO Group

Changing to a SaaS model has held back revenues at patient monitoring equipment supplier LiDCO Group. 

Continue reading... | 20/02/2019

HML Holdings

Property manager HML Holdings is making the immediately earnings enhancing acquisition of a rival London-based lettings manager. 

Continue reading... | 19/02/2019


Ironveld has raised £1.1m at 1.75p a share.

Continue reading... | 19/02/2019

All micro news

Browse by issue
All issues
Popular tags
All tags

betbrokers, financial, gold, health, leisure, media, mobile, resources, services, technology

AIM Micro feeds

Keep up to date with articles published at Subscribe to AIM Micro RSS Feeds